Characterization of Endostatin Binding to Heparin and Heparan Sulfate by Surface Plasmon Resonance and Molecular Modeling

Endostatin (20 kDa) is a C-terminal proteolytic fragment of collagen XVIII that is localized in vascular basement membrane zones in various organs. It binds zinc, heparin/heparan sulfate, laminin, and sulfatides and inhibits angiogenesis and tumor growth. Here we determined the kinetics and affinity of the interaction of endostatin with heparin/heparan sulfate and investigated the effects of divalent cations on these interactions and on the biological activities of endostatin. The binding of human recombinant endostatin to heparin and heparan sulfate was studied by surface plasmon resonance using BIAcore technology and further characterized by docking and molecular dynamics simulations. Kinetic data, evaluated using a 1:1 interaction model, showed that heparan sulfate bound to and dissociated from endostatin faster than heparin and that endostatin bound to heparin and heparan sulfate with a moderate affinity (KD ∼ 2 μm). Molecular modeling of the complex between endostatin and heparin oligosaccharides predicted that, compared with mutagenesis studies, two further arginine residues, Arg47 and Arg66, participated in the binding. The binding of endostatin to heparin and heparan sulfate required the presence of divalent cations. The addition of ZnCl2 to endostatin enhanced its binding to heparan sulfate by ∼40% as well as its antiproliferative effect on endothelial cells stimulated by fibroblast growth factor-2, suggesting that this activity is mediated by the binding of endostatin to heparan sulfate. In contrast, no increase in the antiangiogenic and anti-proliferative activities of endostatin promoted by vascular endothelial growth factor was observed upon the addition of zinc.

[1]  A. Fortier,et al.  Zinc ligand-disrupted recombinant human Endostatin: Potent inhibition of tumor growth, safety and pharmacokinetic profile , 2004, Angiogenesis.

[2]  G. Jayson,et al.  Binding of endostatin to endothelial heparan sulphate shows a differential requirement for specific sulphates. , 2003, The Biochemical journal.

[3]  P. Opolon,et al.  Endostatin exhibits a direct antitumor effect in addition to its antiangiogenic activity in colon cancer cells. , 2003, Human gene therapy.

[4]  B. Ren,et al.  The antiangiogenic and therapeutic implications of endostatin. , 2003, Methods and findings in experimental and clinical pharmacology.

[5]  R. Timpl,et al.  Role of heparan sulfate domain organization in endostatin inhibition of endothelial cell function , 2002, The EMBO journal.

[6]  K. Alitalo,et al.  Endostatin associates with integrin alpha5beta1 and caveolin-1, and activates Src via a tyrosyl phosphatase-dependent pathway in human endothelial cells. , 2002, Cancer research.

[7]  S. Ricard-Blum,et al.  Interaction Properties of the Procollagen C-proteinase Enhancer Protein Shed Light on the Mechanism of Stimulation of BMP-1* , 2002, The Journal of Biological Chemistry.

[8]  R. Timpl,et al.  Structure and Function of Collagen‐Derived Endostatin Inhibitors of Angiogenesis , 2002, IUBMB life.

[9]  V. Sukhatme,et al.  Cellular actions and signaling by endostatin. , 2002, Critical reviews in eukaryotic gene expression.

[10]  Yihai Cao,et al.  Embryonic Stem Cell-Derived Embryoid Bodies Development in Collagen Gels Recapitulates Sprouting Angiogenesis , 2001, Laboratory Investigation.

[11]  B. Olsen,et al.  The role of collagen-derived proteolytic fragments in angiogenesis. , 2001, Matrix biology : journal of the International Society for Matrix Biology.

[12]  D. Mukhopadhyay,et al.  Cell surface glypicans are low-affinity endostatin receptors. , 2001, Molecular cell.

[13]  Anne Imberty,et al.  Characterization of the Stromal Cell-derived Factor-1α-Heparin Complex* , 2001, The Journal of Biological Chemistry.

[14]  T. Sasaki,et al.  Endostatin-induced tyrosine kinase signaling through the Shb adaptor protein regulates endothelial cell apoptosis. , 2000, Blood.

[15]  T. Sasaki,et al.  Variable zinc coordination in endostatin. , 2000, Journal of molecular biology.

[16]  M. Humphries,et al.  Elucidation of the Structural Features of Heparan Sulfate Important for Interaction with the Hep-2 Domain of Fibronectin* , 2000, The Journal of Biological Chemistry.

[17]  S. Libutti,et al.  Endostatin inhibits microvessel formation in the ex vivo rat aortic ring angiogenesis assay. , 2000, Biochemical and biophysical research communications.

[18]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[19]  R. Timpl,et al.  Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin , 1999, The EMBO journal.

[20]  M. Delepierre,et al.  Stromal Cell-derived Factor-1α Associates with Heparan Sulfates through the First β-Strand of the Chemokine* , 1999, The Journal of Biological Chemistry.

[21]  I Que,et al.  Endostatin inhibits VEGF‐induced endothelial cell migration and tumor growth independently of zinc binding , 1999, The EMBO journal.

[22]  David S. Goodsell,et al.  Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998, J. Comput. Chem..

[23]  J. Shiloach,et al.  Zinc-binding of endostatin is essential for its antiangiogenic activity. , 1998, Biochemical and biophysical research communications.

[24]  R. Timpl,et al.  Zinc-dependent dimers observed in crystals of human endostatin. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[25]  R. Timpl,et al.  Structure, function and tissue forms of the C‐terminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatin , 1998, The EMBO journal.

[26]  R. Timpl,et al.  Crystal structure of the angiogenesis inhibitor endostatin at 1.5 Å resolution , 1998, The EMBO journal.

[27]  E. Dejana,et al.  Targeted null-mutation in the vascular endothelial-cadherin gene impairs the organization of vascular-like structures in embryoid bodies. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[28]  William Arbuthnot Sir Lane,et al.  Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth , 1997, Cell.

[29]  E. Dejana,et al.  Embryonic stem cells differentiate in vitro to endothelial cells through successive maturation steps. , 1996, Blood.

[30]  M. Forster,et al.  N.m.r. and molecular-modelling studies of the solution conformation of heparin. , 1993, The Biochemical journal.

[31]  Martin Knoblauch,et al.  MOLCAD — Computer Aided Visualization and Manipulation of Models in Molecular Science , 1992 .

[32]  Odd Gropen,et al.  Gaussian basis sets for the fifth row elements, Mo‐Cd, and the sixth row elements W‐RN , 1987 .

[33]  W. Fair,et al.  Selective binding of zinc ions to heparin rather than to other glycosaminoglycans. , 1981, The Biochemical journal.